Osteoporosis is a condition of the bones in which bone mass is lost; this increases the risk of fracturing your wrists, hips and spine.1 Osteoporosis affects men and women. More than 53 million people in the U.S. already have the condition or are at risk for developing it. Risk factors are either fixed or modifiable.… Read More »
People with HIV who already have resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI) when they start first-line antiretroviral treatment containing the integrase inhibitor dolutegravir were less likely to achieve viral suppression, a large clinical trial in South Africa has reported. NNRTI resistance has not been shown to affect responses to dolutegravir-based treatment previously. The… Read More »
A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »
New Partnership Allows Customers to Leverage Business Email Analytics Solutions Alongside eShore’s Proven Cloud Security Services Cayman Islands, George Town: Leading email and data security firm eShore Ltd today announced a new partnership with timetoreply to resell and deliver business email analytics solutions to organizations in the Caribbean, Bermuda, and Latin America. Collaboration between the… Read More »
The consumer watchdog has put the hard word on private health insurers to pass on profits to policyholders after paying out $ 500 million less in hospital and extras benefits in 2019-20 due to COVID-19 restrictions. The lower benefit payout came after the pandemic limited non-urgent elective surgery and non-urgent extras treatments, including most dental,… Read More »